23 November 2017
News and Views
Links and Services
Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery, reports July's issue of the Inflammatory Bowel Diseases.
In patients with Crohn's disease (CD), the effect of anti-tumor necrosis factor alpha (TNF-α
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors